Development of animal models for demonstrating the activity of chronobiotics or melatonin analogues;Developpement de modeles animaux pour la mise en evidence de l'activite des chronobiotiques ou analogues melatoninergiques

Therapie

Volumn 53, Issue 5, 1998, Pages 439-444

  Guardiola Lemaitre B ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Circadian rhythms; Melatonin; Melatonin agonists; Sleep disturbances; Suprachiasmatic nucleus

Indexed keywords

MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; NEUROHORMONE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CONFERENCE PAPER; FEEDBACK SYSTEM; HORMONE RELEASE; LIGHT DARK CYCLE; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; SLEEP DISORDER; ANIMAL; BIOLOGICAL MODEL; DRUG POTENTIATION; HUMAN; PATHOPHYSIOLOGY; REVIEW; SLEEP STAGE;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; MELATONIN; MODELS, BIOLOGICAL; SLEEP DISORDERS; SLEEP STAGES;

EID: 0032153460     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Klein DC. Circadian rhythms in indole metabolism in the rat pineal gland. In: Schmidt FO, ed. The Neurosciences: Third Study Programme. Cambridge, MA: MIT Press, 1994: 509-515.
2. Arendt J, Aldhous M, English J et al. Some effects of jet lag and their alleviation by melatonin. Ergonomics 1987; 30: 1379-1393.
3. Arendt J. Complex effects of melatonin. Therapie 1998; 53: 479-488.
4. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13: 1177-1185.
5. 1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92: 8734-8738.
6. Petit L, Guardiola B, Delagrange P, Jockers R, Strosberg AD. Signalisation des récepteurs de la mélatonine. Therapie 1998; 53: 421-428.
7. The treatment of sleep disorders of older people. Consensus Statement, NIH Development Conference, 26-28 March 1990.
8. Diagnostic and Statistical Manual of Mental Disorders, IV. Washington, DC: American Psychiatric Association, 1974: 573-578.
9. Armstrong SM. Treatment of sleep disorders by melatonin administration. In: Foldes, Reiter R, eds. Advances in Pineal Research 6. London: John Libbey, 1991: 263-274.
10. Guardiola-Lemaître B. Toxicology of melatonin. J Biol Rhythms 1997; 12: 697-706.
11. Lesieur D, Leclerc V, Chavatte P et al. La mélatonine, prototype pertinent pour l'innovation thérapeutique. Therapie 1998; 53: 429-437.
12. Redman JR, Armstrong SM. Reentrainment of rat circadian activity rhythms: effects of melatonin. J Pineal Res 1988; 5: 203-215.
13. Yous Y, Andrieux J, Howell ME et al. Novel naphtalenic ligands with high affinity for the melatonin receptor. J Med Chem 1992; 35: 1484-1486.
14. Howell HE, Guardiola-Lemaître B, Renard P et al. Naphtalenic ligands reveal melatonin binding site heterogeneity. Endocrine 1994; 979-988.
15. Ying SW, Rusak B, Delagrange P, et al. Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol 1996; 296: 33-42.
16. Delagrange P, Renard P, Caignard DC et al. Development of melatonin analogues. In: Fraschini et al. eds. The Pineal Gland and its Hormones. New York: Plenum Press 1995: 139-153.
17. Koster van Hoffen GC, Mirmiran M, Bos NPA et al. Effects of a novel melatonin analog on circadian rhythms of body temperature and activity in young, middle-aged and old rats. Neurobiol Aging 1993; 14: 565-569.
18. Cassone VM, Chesworth MJ, Armstrong SM. Entrainment of rat circadian rhythms by daily injection of melatonin depends upon the hypothalamic suprachiasmatic nuclei. Physio Behav 1986a; 36: 1111-1121.
19. Moore RY. Organization and function of a central nervous system circadian oscillator. The suprachiasmatic hypothalamic nucleus. Federation Proc 1983; 42: 2783-2789.
20. Lockley SW, Skene DJ, Arendt J et al. Relationships between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 1997; 82: 3763-3770.
21. Cassone VM, Chesworth MJ, Armstrong SM. Dose-dependent entrainment of rat circadian rhythms by daily injection of melatonin. J Biol Rhythms 1986; 1: 219-229.
22. Sack RL, Lewy AJ, Blood ML et al. Melatonin administration to blind people: phase advances and entrainment. J Biol Rhythms 1991; 6: 249-261.
23. Delagrange P, Mason R, Redman J et al. Effect of S 20098, a potent melatonin agonist on rat temperature and activity circadian rhythm. Sleep Res 1993; 22: 616.
24. Bonnefond C, Martinet L, Lesieur D et al. Characterization of S 20098: a new melatonin analog. In: Touitou Y, Arendt J, Pévet P, eds. Melatonin and the Pineal Gland - from Basic Science to Clinical Application. Amsterdam: Elsevier 1993: 123-126.
25. Redman JR, Guardiola-Lemaitre B. The melatonin agonist: S20098: effects on the rat circadian system. In: Touitou Y, Arendt J, Pévet P, eds. Melatonin and the Pineal Gland - from Basic Science to Clinical Application. Amsterdam: Elsevier 1993: 127-130.
26. Armstrong SM, McNulty OM, Guardiola-Lemaitre B et al. Successful use of S 20098 and melatonin in an animal model of delayed sleep phase syndrome [DSPS]. Pharmacol Biochem Behav 1993, 46, 45-49.
27. Van Gool WA, Mirmiran M. Aging and circadian rhythms. In: Progress In Brain Research 70: Aging of the Brain and Alzheimer's Disease. Amsterdam: Elsevier 1986: 255-279.
28. Ancoli-Israel, S, Parker, L, Sinae, R et al. Sleep fragmentation in patients from a nursing home. J Gerontol 1989; 44: M18-M21.
29. Witting W, Mirmiran M, Bos NPA et al. Effect of light intensity on diurnal sleep-wake distribution in young and old rats. Brain Res Bull 1993; 30: 157-162.
30. Satinoff E, Li H, Tcheng TK et al. Do the suprachismatic nuclei oscillate in old rats as they do in young ones? Am J Physiol 1993; 265: R1216-R1222.